Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 19, 2018
Pharmacy Choice - News - U.S. Pharmaceutical Industry - August 19, 2018

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/19/18 - Week Ahead In Pharmaceuticals: 7 Stocks To Watch (TNXP, REGN, KALA...)
Barely days after striking down Regeneron Pharmaceuticals Inc.' s request for an updated label for EYLEA, the FDA greenlighted the same on Friday, paving way for a 12- week dosing regimen of the drug for patients with wet age-related macular degeneration. Mylan's EpiPen, the most-widely prescribed epinephrine auto-injector in the U.S., and the one
8/18/18 - 11 Idaho counties take on Walmart, CVS, drug companies in opioid lawsuit [The Idaho Statesman]
Aug. 17 Several Idaho counties are suing drug makers and retailers, accusing them of being responsible for an opioid epidemic that has killed and harmed Idahoans. The lawsuit was filed Friday in federal court by Adams, Blaine, Boise, Bonneville, Caribou, Cassia, Elmore, Latah, Minidoka, Owyhee and Payette counties. "In Idaho, prescription opioid
8/18/18 - Aerie Reports Positive Study Results for Eye Pressure Drug Rhopressa
The North Carolina Biotechnology Center issued the following news release:. Aerie Pharmaceuticals, an ophthalmic pharmaceutical company based in Durham, has reported positive clinical results for Rhopressa, its once-daily eye drop approved for the reduction of elevated eye pressure, a cause of glaucoma. "This study confirms that in patients with e
8/18/18 - Albumin (As Excipient) Market to Reach US$ 1200 Mn by 2019
Albany, NY 08/18/2018 Global Albumin Market Snapshots. The global albumin market was valued at US$ 750 Mn in 2017 and is anticipated to reach US$ 1200 Mn by 2026 at a CAGR of over 5.0% from 2018 to 2026. For instance, in May 2017, China's Food and Drug Administration granted approval to clinical trials of human blood albumin produced from
8/18/18 - Army Seeks Tick-Borne Encephalitis Vaccine Development
The U.S. Army Medical Research Acquisition Activity has issued a sources sought notice for the development of tick-borne encephalitis vaccine for use by U.S. service members. Excerpts of the notice state: The vaccine must be European Medicines Agency approved, and shall achieve U.S. Food and Drug Administration licensure. For more information about
8/18/18 - As Opioid Overdose Deaths Increase, Senator Markey Queries FDA About Inappropriate Fentanyl Prescribing
An analysis of the FDA' s Risk Evaluation and Mitigations Strategies- a series of specific actions required by the FDA of a drug manufacturer that is intended to lessen the risks of the drug being sold- for this specific class of fentanyl medications indicated that 42 percent of these prescriptions may not have been prescribed appropriately.
8/18/18 - Bunion (Hallux Valgus) Treatment Market Have Turned Into a $8 Billion Industry Growing at a CAGR of 6.5% - Forecast 2108-2023: Market Research Future published a study report on Bunion (Hallux Valgus) Treatment Market. This report studies the global
Pune, India 08/18/2018 Market Highlights:. A bunion is an enlargement of bone or tissue around the joint at the base of the big toe. The big toe may turn toward the second toe.
8/18/18 - Clear River Enviro Assigned Patent for Apparatus for Treating Pharmaceutical Waste
Clear River Enviro, Sugar Land, Texas, has been assigned a patent developed by four co-inventors for an "apparatus for treating pharmaceutical waste." The co-inventors are Michael Sanborn, Carrolton, Texas, Todd McGee, Mesa, Arizona, Mark Macdonell, Sugar Land, Texas, and Scott Kosch, Austin, Texas. Written by Subhashree Samal; edited by Sudarshan
8/18/18 - Company Profile for LuckyVitamin
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Founded in 2005, LuckyVitamin is an industry-leading global e-commerce destination for health and wellness, natural and organic products, vitamins, nutritional supplements, sports and fitness nutrition, food, beauty, skincare, pet and natural home. LuckyVitamin offers premium
8/18/18 - County plans to join lawsuit against opioid manufacturers, distributors [The Daily Star-Journal, Warrensburg, Mo.]
Aug. 17 WARRENSBURG Johnson County commissioners plan to join a nationwide lawsuit against the manufacturers and distributors of opioids to recover funds spent in fighting and abating the opioid epidemic. Attorney Dirk Vandever of the Popham Law Firm, Kansas City, one of three law firms participating in the suit, said drug manufacturers and dis
8/18/18 - Drug Delivery Systems Market Projected to Reach US$ 900 Bn by 2019
Albany, NY 08/18/2018 Drug Delivery Systems Market: Snapshot. The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. For instance, on September 2017, Baxter International Inc. announced the launch of De
8/18/18 - EpiPen: NJ consumers squeezed by cost to get generic option from Teva [Asbury Park Press, N.J.]
Aug. 17 Families who rely on the expensive EpiPen to save their children during a severe allergy attack may soon have a lower-cost generic option thanks to a pharmaceutical company moving to New Jersey. "I think it's fantastic," said Amy McVey, 40, of Long Branch, whose 11- year-old son uses the injectable drug. Teva Pharmaceuticals Inc., the Is
8/18/18 - Faso Highlights FDA Approval of Generic EpiPen Auto-Injector
Rep. Faso had written to FDA Commissioner Dr. At the time, the FDA had just added epinephrine auto-injectors to the FDA' s list of existing drug shortages. I'm glad to see the FDA approve additional effective and safe devices that will lower costs for consumers and expand access. "
8/18/18 - FDA Clears SPR Therapeutics Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management [Tehran Times (Iran)]
SPR Therapeutics, Inc., a leader in neurostimulation technology for pain, today announced that the U.S. Food and Drug Administration has cleared its SPRINTendura and extensa Peripheral Nerve Stimulation Systems. With the ease of use and dual lead capabilities weve built into the SPRINT System we look forward to advancing the early use of neurostimu
8/18/18 - Intravenous Immunoglobulin (IVIG) Market Value to Reach US$14,923.2 Million 2024
Albany, NY 08/18/2018 Global Intravenous Immunoglobulin Market: Analyst's Estimations. In the recent past, IVIG have proven their worth in treating autoimmune diseases such as primary humoral immunodeficiency, multiple sclerosis, immune thrombocytopenia purpura, autoimmune haemolytic anemia, and Kawasaki syndrome. On the basis of indication,
8/18/18 - Midwest Products and Engineering Assigned Patent for Pharmaceutical Management Storage Cabinet
Midwest Products and Engineering, Milwaukee, Wisconsin, has been assigned a patent developed by eight co-inventors for "pharmaceutical management storage cabinet." The co-inventors are Natasha L. Lehndorf, Cudahy, Wisconsin, Tony Le, New Berlin, Wisconsin, Jeff George, Chicago, Illinois, Lou Lucchi, Chandler, Arizona, Nadder D. Sahar, Milwaukee, Wi
8/18/18 - Motif Bio to Present Iclaprim Data at ESCMID/ASM Conference [Syrian Arab News Agency]
-Motif Bio plc, a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that iclaprim data will be presented at the upcoming European Society of Clinical Microbiology and Infectious Diseases/ American Society For Microbiology Conference on Drug Development to Meet the Challenge of Antimicrobial...
8/18/18 - Non-Therapeutic Antibiotics for Food Animals Market Analysis by 2025: Top Players Like Bayer AG, AG Sanofi, Virbac, AG Zoetis, Ceva Sante Animale: The latest report studies the global Non-Therapeutic Antibiotics for Food Animals market status and for
New York, NY 08/18/2018 The Top key vendors in Non-Therapeutic Antibiotics for Food Animals Market include are AG Zoetis, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck& Co., Inc., Bayer AG, AG Sanofi, Ceva Sante Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals. You Can Download Free Sample Copy of Non-Therapeutic Antib
8/18/18 - Ophthalmology Devices Market: Global Product Intelligence, Analysis, Opportunities and Forecast to 2024: Some of the prominent participants in the Global Ophthalmology Devices Market are Carl Zeiss Meditec AG, Abbott Medical Optics, Inc., Bausch & Lo
Pune, Maharashatra 08/17/2018 " Infinium Global Research has produced a new premium report Ophthalmology Devices Market. The report also deep dives into the sub-segments of Ophthalmology Devices Market by devices and application through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW. Some of the prom
8/18/18 - Sen. Grassley Requests FTC Assessment of Pharmaceutical Supply Chain Intermediaries and Recent Consolidation
Senate Judiciary Committee Chairman Chuck Grassley of Iowa today wrote to Federal Trade Commission Chairman Joseph Simons requesting the FTC conduct an assessment of recent and ongoing consolidation in the pharmaceutical supply chain and its potential impact on prescription drug prices for U.S. consumers. In the past, the FTC has asserted that allo
8/18/18 - Sens. Smith, Warren Raise Questions About Accuracy of Secretary Azar's Testimony Blaming Pharmacy Benefit Managers for High Drug Prices
Tina Smith and Elizabeth Warren questioned Health and Human Services Secretary Alex Azar about his potentially misleading statements during his Senate testimony in which he blamed pharmacy benefit managers and drug distributors for drug manufacturers' ongoing refusal to meaningfully reduce drug prices. Despite President Trump's promises that drug..
8/18/18 - Sirnaomics cleared to start first trial of RNAi lead in cancer [T-break Tech (Middle East)]
Sirnaomics founder and CEO Patrick Lu, Ph.D., said the patisiran approval validates the RNAi class of therapeutics and it is our belief that the industry will see great enthusiasm and expanded discovery and development of novel RNAi therapeutics for many disease applications. The Gaithersburg, Maryland- based biotech has been working on RNAi therap
8/18/18 - ViiV Healthcare announces positive results from phase III ATLAS study of long-acting, injectable 2DR for HIV treatment [Tehran Times (Iran)]
ViiV Healthcare announced positive headline results from its global, phase III ATLAS study of a long-acting, injectable two-drug regimen for the treatment of HIV. ATLAS was designed to establish if HIV-1-infected adult participants who had maintained viral suppression for at least six months, on a daily oral regimen comprised of two nucleoside reve
8/18/18 - Warren, Smith Raise Questions About Accuracy of Secretary Azar's Testimony Blaming PBMs for High Drug Prices
Elizabeth Warren, D- Massachusetts, issued the following news release:. United States Senators Elizabeth Warren and Tina Smith today questioned Health and Human Services Secretary Alex Azar about his potentially misleading statements during Senate testimony in which he blamed pharmacy benefit managers and drug distributors for drug manufacturers'..
8/17/18 - "Method For Manufacturing Asenapine-Containing Patch" in Patent Application Approval Process (USPTO 20180207108)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors SONOBE, Atsushi; YASUKOCHI, Takashi, filed on July 21, 2016, was made available online on July 26, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Hisamitsu Pharmaceutical Co
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415